Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.57B |
| 2 |
NextEra Energy, Inc.
NEE
|
+$1.54B |
| 3 |
RTX Corp
RTX
|
+$1.46B |
| 4 |
Air Products & Chemicals
APD
|
+$1.19B |
| 5 |
Microsoft
MSFT
|
+$1.18B |
Top Sells
| 1 |
Starbucks
SBUX
|
+$2.38B |
| 2 |
Netflix
NFLX
|
+$1.87B |
| 3 |
Comcast
CMCSA
|
+$1.55B |
| 4 |
Baker Hughes
BKR
|
+$1.21B |
| 5 |
Amazon
AMZN
|
+$1.12B |
Sector Composition
| 1 | Technology | 26.58% |
| 2 | Healthcare | 16.23% |
| 3 | Industrials | 12.73% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Fiserv
FI
$73B
| $71.3M | 0.02% |
536,700
| – | – |
|
302
IDEAYA Biosciences
IDYA
$2.16B
| $70.3M | 0.02% |
1,976,870
+600,000
| +44% | +$21.3M |
|
303
Emerson Electric
EMR
$76B
| $66.7M | 0.02% |
684,791
-508
| -0.1% | -$49.4K |
|
304
GSK
GSK
$82.2B
| $65M | 0.02% |
1,753,035
| – | – |
|
305
Matsons
MATX
$3.29B
| $63.5M | 0.02% |
579,528
| – | – |
|
306
Nutrien
NTR
$27.7B
| $63.1M | 0.02% |
1,119,683
| – | – |
|
307
Denali Therapeutics
DNLI
$2.07B
| $62.4M | 0.02% |
2,909,528
+29,205
| +1% | +$627K |
|
308
Guardant Health
GH
$6.85B
| $62.3M | 0.02% |
2,301,472
| – | – |
|
|
WRK
309
DELISTED
WestRock Company
WRK
| $60.1M | 0.01% |
1,447,126
+1,372
| +0.1% | +$57K |
|
|
CHX
310
DELISTED
ChampionX
CHX
| $59.2M | 0.01% |
2,025,494
| – | – |
|
311
Trex
TREX
$6.48B
| $58.4M | 0.01% |
705,297
+66,720
| +10% | +$5.52M |
|
|
312
Starbucks
SBUX
$93.1B
| $57.3M | 0.01% |
596,850
-24,769,143
| -98% | -$2.38B |
|
313
McGrath RentCorp
MGRC
$3.01B
| $55.9M | 0.01% |
+467,729
| New | +$55.9M |
|
314
Euronet Worldwide
EEFT
$3.6B
| $54.2M | 0.01% |
534,424
-764,360
| -59% | -$77.6M |
|
315
Alcoa
AA
$8.61B
| $54.2M | 0.01% |
1,592,742
| – | – |
|
316
Eastman Chemical
EMN
$7.71B
| $54M | 0.01% |
+601,726
| New | +$54M |
|
317
Enbridge
ENB
$107B
| $53.7M | 0.01% |
1,492,161
-1,567,621
| -51% | -$56.4M |
|
318
Comfort Systems
FIX
$26.6B
| $52.7M | 0.01% |
256,244
-42,337
| -14% | -$8.71M |
|
319
Encompass Health
EHC
$12.7B
| $52.6M | 0.01% |
787,849
| – | – |
|
320
Grifois
GRFS
$6.72B
| $50.1M | 0.01% |
4,331,222
| – | – |
|
321
Glacier Bancorp
GBCI
$5.8B
| $49.6M | 0.01% |
1,200,908
+666,478
| +125% | +$27.5M |
|
322
Applied Digital
APLD
$4.89B
| $49.5M | 0.01% |
7,337,288
+5,945,559
| +427% | +$40.1M |
|
|
ESGR
323
DELISTED
Enstar Group
ESGR
| $48.9M | 0.01% |
165,978
| – | – |
|
324
CBIZ
CBZ
$3.01B
| $47.8M | 0.01% |
+764,193
| New | +$47.8M |
|
325
State Street
STT
$31.9B
| $46.7M | 0.01% |
602,643
-40
| -0% | -$3.1K |
|